Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
Deepak L. Bhatt(Mount Sinai Hospital), for the CRUSADE Investigators, Christopher P. Cannon(Brigham and Women's Hospital), Neal S. Kleiman(Houston Methodist), W. Frank Peacock(Hennepin Healthcare Research Institute), Ralph G. Brindis, E. Magnus Ohman(Tarzana Treatment Centers), Charles V. Pollack, Matthew T. Roe(Clinical Research Institute), Robert A. Harrington(Clinical Research Institute), William E. Boden(VA New England Healthcare System), Sidney C. Smith(University of North Carolina at Chapel Hill), Anita Y. Chen(University of Rochester Medicine), Judith S. Hochman(New York University), David J. Cohen(Baim Institute for Clinical Research), Yun Li(Duke University), Jorge F. Saucedo, Peter B. Berger, Eric D. Peterson, W. Brian Gibler(University of Cincinnati), C. Michael Gibson(Baim Institute for Clinical Research), Adam B. Greenbaum(Brigham and Women's Hospital)
Cited by 572
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k